Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Zileuton sodium

😃Good
Catalog No. T21836Cas No. 118569-21-4
Alias Abbott 64077 sodium, A 64077 sodium

Zileuton sodium is a selective and reversible 5-lipoxygenase (5-LOX) inhibitor that suppresses LTB4 synthesis. It significantly reduces arachidonic acid-induced ear edema in mice (ED50 = 31 mg/kg) and is suitable for inflammation research.

Zileuton sodium

Zileuton sodium

😃Good
Catalog No. T21836Alias Abbott 64077 sodium, A 64077 sodiumCas No. 118569-21-4
Zileuton sodium is a selective and reversible 5-lipoxygenase (5-LOX) inhibitor that suppresses LTB4 synthesis. It significantly reduces arachidonic acid-induced ear edema in mice (ED50 = 31 mg/kg) and is suitable for inflammation research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$98-In Stock
10 mg$155-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Zileuton sodium is a selective and reversible 5-lipoxygenase (5-LOX) inhibitor that suppresses LTB4 synthesis. It significantly reduces arachidonic acid-induced ear edema in mice (ED50 = 31 mg/kg) and is suitable for inflammation research.
In vitro
Zileuton sodium inhibits 5-hydroxydocosahexaenoic acid synthesis in rat basophilic leukemia cell 20,000 x g supernatant and rat polymorphonuclear leukocytes (PMNL), with IC50 = 0.5/0.3 mM. It inhibits leukotriene (LT) B4 synthesis in rat PMNL (IC50 = 0.4 μM), human PMNL (IC50 = 0.4 μM), and human whole blood (IC50 = 0.9 μM). Inhibition of human PMNL LTB4 biosynthesis is readily reversed by simple washing procedures [1].
In vivo
Zileuton sodium (1200 mg/kg) inhibited polyp formation in the colon and small intestine of APCΔ468 rats. Zileuton sodium treatment suppressed proliferation rates of non-epithelial cells within polyps and increased apoptosis within polyps, contributing to reduced polyp incidence in the small intestine and colon of Zileuton sodium-fed APCΔ468 mice [4].
SynonymsAbbott 64077 sodium, A 64077 sodium
Chemical Properties
Molecular Weight258.27
FormulaC11H11N2NaO2S
Cas No.118569-21-4
SmilesO=C(N(C(C)C1=CC2=C(C=CC=C2)S1)[O-])N.[Na+]
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (309.75 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.8719 mL19.3596 mL38.7192 mL193.5958 mL
5 mM0.7744 mL3.8719 mL7.7438 mL38.7192 mL
10 mM0.3872 mL1.9360 mL3.8719 mL19.3596 mL
20 mM0.1936 mL0.9680 mL1.9360 mL9.6798 mL
50 mM0.0774 mL0.3872 mL0.7744 mL3.8719 mL
100 mM0.0387 mL0.1936 mL0.3872 mL1.9360 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Zileuton sodium | purchase Zileuton sodium | Zileuton sodium cost | order Zileuton sodium | Zileuton sodium chemical structure | Zileuton sodium in vivo | Zileuton sodium in vitro | Zileuton sodium formula | Zileuton sodium molecular weight